A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD)

NCT03697265 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Premenstrual Dysphoric Disorder

Interventions

DRUG: Sepranolone (UC1010) low dose
DRUG: Sepranolone (UC1010) high dose
DRUG: Placebo

Sponsor

Asarina Pharma

Collaborators

[object Object]